Tinampay, Kilneth .
HRN: 08-33-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
CEFTRIAXONE 1G (VIAL)
09/23/2023
09/29/2023
IV
1.3gm
Q12
URTI, T/C Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes